Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Mar 21;8(1):4980.
doi: 10.1038/s41598-018-23344-z.

Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis

Joel Philip Samuels  1 , Aashna Sood  2 , Jonathon R Campbell  3 , Faiz Ahmad Khan  4   5   6 , James Cameron Johnston  7   8
Affiliations
Meta-Analysis

Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis

Joel Philip Samuels et al. Sci Rep. .

Abstract

Little is known about the impact of comorbidities on multidrug resistant (MDR) and extensively drug resistant (XDR) tuberculosis (TB) treatment outcomes. We aimed to examine the effect of human immunodeficiency virus (HIV), diabetes, chronic kidney disease (CKD), alcohol misuse, and smoking on MDR/XDRTB treatment outcomes. We searched MEDLINE, EMBASE, Cochrane Central Registrar and Cochrane Database of Systematic Reviews as per PRISMA guidelines. Eligible studies were identified and treatment outcome data were extracted. We performed a meta-analysis to generate a pooled relative risk (RR) for unsuccessful outcome in MDR/XDRTB treatment by co-morbidity. From 2457 studies identified, 48 reported on 18,257 participants, which were included in the final analysis. Median study population was 235 (range 60-1768). Pooled RR of unsuccessful outcome was higher in people living with HIV (RR = 1.41 [95%CI: 1.15-1.73]) and in people with alcohol misuse (RR = 1.45 [95%CI: 1.21-1.74]). Outcomes were similar in people with diabetes or in people that smoked. Data was insufficient to examine outcomes in exclusive XDRTB or CKD cohorts. In this systematic review and meta-analysis, alcohol misuse and HIV were associated with higher pooled OR of an unsuccessful outcome in MDR/XDRTB treatment. Further research is required to understand the role of comorbidities in driving unsuccessful treatment outcomes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flowchart showing Selection Process for Included Articles.
Figure 2
Figure 2
(a) Relative Risk of primary outcome in MDR/XDRTB patients living with HIV compared to those without HIV infection. (b) Relative Risk of mortality in MDR/XDRTB patients living with HIV compared to those without HIV infection.
Figure 3
Figure 3
Relative Risk of primary outcome in MDR/XDRTB patients with DM compared to those without DM.
Figure 4
Figure 4
Relative Risk of primary outcome in MDR/XDRTB patients that smoke compared to non-smokers.
Figure 5
Figure 5
(a) Relative Risk of primary outcome in MDR/XDRTB patients with alcohol misuse (AM) compared to those without alcohol misuse (Non-AM). (b) Relative Risk of default in MDR/XDRTB patients with alcohol misuse (AM) compared to those without alcohol misuse (Non-AM).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Guidelines for the programmatic management of drug-resistant tuberculosis: Emergency update 2008.pdf [Internet]. [cited 2016 May 20]. Available from: http://apps.who.int/iris/bitstream/10665/43965/1/9789241547581_eng.pdf.
    1. The Global MDR-TB & XDR-TB Response Plan 2007–2008.pdf [Internet]. [cited 2016 May 20]. Available from: http://www.who.int/tb/publications/2007/global_response_plan.pdf.
    1. Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS ONE Electron Resour. 2009;4:e6914. doi: 10.1371/journal.pone.0006914. - DOI - PMC - PubMed
    1. Laserson KF, et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. J Tuberc. 2005;9:640–645. - PubMed
    1. Bastos ML, et al. Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis. Clin Infect Dis. 2014;59:1364–1374. doi: 10.1093/cid/ciu619. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances